Inicio Catálogo Calidad y COA Acerca de Contacto Carrito
Ver catálogo
Envío gratuito en pedidos superiores a 9 · $7.99 EE. UU. (48 h) · $14.99 a todo el mundo (5 días) · Embalaje discreto · Criptomoneda aceptada
Liofilizado · 5 mg / vial AOD-9604 5 mg / vial — Vial de péptido verificado por HPLC
Metabólico y peso 5 mg / vial

AOD-9604 5mg — hGH Lipolytic Fragment (177-191 + Tyr)

Modified hGH fragment · Isolated lipolytic activity · No diabetogenic effect

Premium Grade

Modified C-terminal fragment of human growth hormone — isolated lipolytic activity without proliferative or diabetogenic effects.

Número CAS
221231-10-3
Peso molecular
1 815.10 Da
Pureza
≥ 99.0% (HPLC)
Almacenamiento
−20 °C, liofilizado
Secuencia de aminoácidos Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe (hGH 177-191 + N-Tyr)
Elija su paquete
Paga hoy $60 3 viales · $20/vial
Gratis en pedidos superiores a 9$7.99 a EE. UU. (48 h) · $14.99 a todo el mundo (5 días hábiles)
Embalaje discretoMailer aislado liso, sin nombre del compuesto en el exterior.

Certificado de análisis

Informe analítico por lote — HPLC, ESI-MS, endotoxina LAL, metales pesados, esterilidad

Lote actualAOD343
Liberado2026-04-16
Pureza HPLC99.07%
Endotoxina (LAL)Aprobado · < 0,5 EU/mg

Acerca de AOD-9604

Buy AOD-9604 5mg at IGF1 Shop. AOD-9604 is a synthetic 16-amino-acid analog of the lipolytic fragment of human growth hormone (hGH 177-191) with an additional N-terminal tyrosine. The modification retains the lipolytic and anti-lipogenic activities of full-length hGH while lacking the diabetogenic and cell-proliferative effects. Each AOD-9604 5mg vial is HPLC-verified at ≥99% purity, ESI mass-spec confirmed against the theoretical 1,815.10 Da molecular weight, and accompanied by a per-lot Certificate of Analysis. CAS 221231-10-3.

También conocido como: AOD-9604 · AOD 9604 · hGH fragment 177-191 · Lipolytic peptide

AOD-9604 — Mecanismo y especificaciones

AOD-9604 is a synthetic 16-amino acid analog of the lipolytic fragment of human growth hormone (hGH 177-191) with an additional N-terminal tyrosine. It retains the lipolytic and anti-lipogenic activities of full-length hGH while lacking the diabetogenic and cell-proliferative effects.

Calidad y criterios de liberación

Cada lote de AOD-9604 se libera solo después de pasar la HPLC en fase inversa (≥ 99 % de pureza en área a 220 nm frente a un estándar de referencia), la confirmación del peso molecular por espectrometría de masas ESI, y la prueba de endotoxinas LAL (Limulus Amebocyte Lysate) por debajo de 0,5 EU/mg. El Certificado de análisis específico del lote se proporciona con el pedido y está disponible previa solicitud antes de la compra.

FAQ

AOD-9604 — Preguntas frecuentes

What is AOD-9604?
AOD-9604 (Anti-Obesity Drug 9604) is a synthetic 16-amino-acid analog of the C-terminal lipolytic fragment of human growth hormone (residues 177-191) with an added N-terminal tyrosine. It mimics the fat-mobilizing activity of full-length hGH without raising blood glucose or stimulating IGF-1 — the diabetogenic and proliferative effects that limit hGH dosing.
What is the typical AOD-9604 dose?
Common protocols use 250-500 mcg per day subcutaneously, taken on an empty stomach in the morning. A 5mg vial reconstituted with 2mL bacteriostatic water yields 250 mcg per 0.1mL — so a typical dose is 0.1-0.2mL (10-20 units on a U-100 insulin syringe).
How is AOD-9604 tested?
Each AOD-9604 lot is HPLC-tested to ≥99% purity, confirmed by ESI mass spectrometry, and LAL endotoxin tested below 0.5 EU/mg. ISO 17025-accredited third-party labs perform the testing; the per-lot COA accompanies every shipment.
How do I reconstitute and store AOD-9604?
Add 2mL of bacteriostatic water to the vial, swirl gently, do not shake. Store reconstituted AOD-9604 refrigerated at 2-8°C and use within 30 days. Lyophilized vials are stable at -20°C for 24+ months protected from light.
Do you ship AOD-9604 internationally?
Yes — AOD-9604 ships worldwide in plain, discreet packaging with tracked delivery. Orders over $59 ship free. Crypto and card payment both accepted.